L3VLUP
ProSign in

ASND in the 13F filings

Ascendis Pharma A · CUSIPs 04351P101, K08588103

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 5 Nov 2024
Managers listing it
15
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 11 listed it in both
Shares listed
20,516,120
combined, among listed positions
Reported value
$3.1bn
combined, at the quarter end

Among the 94 comparable managers: 11 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing ASND in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

15 of 15 holders

ActionFiling
Fidelity (FMR LLC)4,907,846$733munder 0.1%Trimmed-14,7095 Nov 2026 (the filing on sec.gov)
Artisan Partners LP4,411,111$659m0.98%Added+116,08212 Nov 2024 (the filing on sec.gov)
Janus Henderson Group Ltd4,186,694$625m0.32%Added+267,88114 Nov 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc2,121,128$317munder 0.1%Added+336,98014 Nov 2024 (the filing on sec.gov)
MFS Investment Management1,866,986$279m0.08%Added+155,97112 Nov 2024 (the filing on sec.gov)
Wellington Management Group LLP1,261,480$188munder 0.1%Trimmed-1,351,37614 Nov 2024 (the filing on sec.gov)
Point72 Asset Management LP495,547$74m0.19%Newnew14 Nov 2024 (the filing on sec.gov)
Voloridge Investment Management LLC397,013$59m0.22%Added+50,79514 Nov 2024 (the filing on sec.gov)
Woodline Partners LP235,018$35m0.30%Added+36,25214 Nov 2024 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC228,525$34m0.23%Added+130,38414 Nov 2024 (the filing on sec.gov)
Marshall Wace LLP221,075$33munder 0.1%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Acadian Asset Management LLC120,894$18m0.06%Trimmed-21,27112 Nov 2024 (the filing on sec.gov)
Moore Capital Management LP40,000$6.0m0.11%Newnew14 Nov 2024 (the filing on sec.gov)
Baillie Gifford & Co21,403$3.2munder 0.1%Trimmed-49,6685 Nov 2024 (the filing on sec.gov)
Farallon Capital Management LLC1,400$209kunder 0.1%Newnew14 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (3)

Exited (1)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
15 in Q3 2024 to 12 in Q2 2026

Tracked managers listing it, at least.

05101520201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ASND by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20171$2.1mn.a.n.a.
Q3 20172$4.7mn.a.n.a.
Q4 20171$4.8mn.a.n.a.
Q1 20186$362mn.a.n.a.
Q2 20184$310mn.a.n.a.
Q3 20183$359mn.a.n.a.
Q4 20184$638mn.a.n.a.
Q1 20198$1.7bnn.a.n.a.
Q2 20198$1.9bnn.a.n.a.
Q3 20198$1.7bnn.a.n.a.
Q4 201912$2.8bnn.a.n.a.
Q1 20209$2.3bnn.a.n.a.
Q2 20208$3.2bnn.a.n.a.
Q3 20209$4.1bnn.a.n.a.
Q4 202012$4.5bnn.a.n.a.
Q1 202110$3.4bnn.a.n.a.
Q2 202110$3.4bnn.a.n.a.
Q3 202110$4.5bnn.a.n.a.
Q4 202111$3.7bnn.a.n.a.
Q1 202210$3.3bnn.a.n.a.
Q2 20229$2.5bnn.a.n.a.
Q3 202212$2.7bnn.a.n.a.
Q4 202212$3.0bnn.a.n.a.
Q1 20239$2.6bnn.a.n.a.
Q2 20238$1.9bnn.a.n.a.
Q3 20238$2.0bnn.a.n.a.
Q4 202311$2.8bn57
Q1 202416$3.4bn106
Q2 202414$2.8bn87
Q3 202415$3.1bn115
Q4 202411$2.6bn67
Q1 202513$3.2bn76
Q2 202511$3.2bn56
Q3 202515$3.7bn68
Q4 202514$3.7bn1614
Q1 202610$3.1bn725
Q2 202612$4.3bn199

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ASND and LLY →ASND and JNJ →ASND and VRTX →Choose a stock to compare with ASND →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ASND, latest filings →Back to the 13F Explorer →